'Host-directed therapy' could treat infectious diseases – including COVID – and limit drug-resistance
(Version anglaise seulement)
par Christian Doerig, Professor, RMIT University
Genia Burchall, RMIT University
Jack Adderley, Postdoctoral research fellow, RMIT University
Tayla Williamson, RMIT University
Classical antibiotics that directly kill pathogens are prone to elicit drug-resistance. Targeting host enzymes required for pathogen survival offers can limit the emergence of resistance.
Lire l'article complet
© La Conversation
-
dimanche 3 avril 2022
